• Venture Capital Investment Activity – 26 July 2012

    by  • July 26, 2012 • Data

    A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week.

    VM Index subscribers see full details of all Venture Capital deals from the past week plus profiles and analysis of thousands of investors and venture-backed companies.



    Total No. Deals

    NA

    EU

    Total Raised $

    Total Raised €

    68

    50

    18

    529.5

    431.8

     

    North America

     

    No. Deals

    Total $

    Total €

    Average $

    Average €

           50

    495.8

    404.3

    11.8

    9.6

     

    Europe

     

    No. Deals

    Total $

    Total €

    Average $

    Average €

    18

    33.7

    27.5

    2.6

    2.1

     

     

    Breakdown By Sector

     

    Life Sciences

     

    No. Deals

    NA

    EU

    Total $

    Total €

    11

    8

    3

    102.1

    83.3

    Average Deal NA & EU

    $

     

    14.6

    11.9

     

     

    Largest Deals

     

    Company Name

    Region

    Stage

    $m

    €m

    Agile Therapeutics

    NA

    SVR

    40.0

    32.6

    Subitec

    EU

    SVR

    5.5

    4.5

     

     

     TMT

     

    No. Deals

    NA

    EU

    Total $

    Total €

    57

    42

    15

    427.4

    348.5

    Average Deal NA & EU

    $

     

    8.9

    7.3

     

     

    Largest Deals

     

    Company Name

    Region

    Stage

    $m

    €m

    Fab.com

    NA

    SVR

    105.0

    85.5

    Mysportgroup

    EU

    SVR

    9.8

    8.0

     

     Exits

     

    Total No. Exits

    LS

    TMT

    NA

    EU

    NA

    EU

    Acquisition

    2

    -

    5

    -

    IPO

    2

    -

    -

    -

     




    This Week In Venture Capital is brought to you by VM Index – Venture Capital made easier

    VM Index is an online IT, Life Science, Biotech & Med Tech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.


    About